Multiple sclerosis meets systems immunology - Authors' reply
- PMID: 34687629
- DOI: 10.1016/S1474-4422(21)00327-6
Multiple sclerosis meets systems immunology - Authors' reply
Conflict of interest statement
AB-O reports grants and personal fees from Biogen Idec, Genentech–Roche, Merck–EMD Serono, and Novartis; and personal fees from GlaxoSmithKline, MedImmune, Bristol-Myers Squibb–Celgene–Receptos, Sanofi-Genzyme, Atara Biotherapeutics, Janssen–Actelion, Accure, and Gossamer. RL declares no competing interests.
Comment in
-
Multiple sclerosis meets systems immunology.Lancet Neurol. 2021 Nov;20(11):887-888. doi: 10.1016/S1474-4422(21)00325-2. Lancet Neurol. 2021. PMID: 34687627 No abstract available.
Comment on
-
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances.Lancet Neurol. 2021 Jun;20(6):470-483. doi: 10.1016/S1474-4422(21)00063-6. Epub 2021 Apr 27. Lancet Neurol. 2021. PMID: 33930317 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
